Dr Manoj Doss, DO - Medicare Preventive Medicine in Eden Prairie, MN

Dr Manoj Doss, DO is a medicare enrolled "Preventive Medicine - Occupational Medicine" physician in Eden Prairie, Minnesota. He graduated from medical school in 2015 and has 9 years of diverse experience with area of expertise as Preventive Medicine. He is a member of the group practice Healthpartners Medical Group and his current practice location is 9300 Hennepin Town Rd, Eden Prairie, Minnesota. You can reach out to his office (for appointments etc.) via phone at (651) 280-8774.

Dr Manoj Doss is licensed to practice in Minnesota (license number 63476) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1487049599.

Contact Information

Dr Manoj Doss, DO
9300 Hennepin Town Rd,
Eden Prairie, MN 55347-3072
(651) 280-8774
Not Available



Physician's Profile

Full NameDr Manoj Doss
GenderMale
SpecialityPreventive Medicine
Experience9 Years
Location9300 Hennepin Town Rd, Eden Prairie, Minnesota
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Manoj Doss graduated from medical school in 2015
  NPI Data:
  • NPI Number: 1487049599
  • Provider Enumeration Date: 04/06/2015
  • Last Update Date: 09/30/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 9638483282
  • Enrollment ID: I20200430001241

Medical Identifiers

Medical identifiers for Dr Manoj Doss such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1487049599NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208D00000XGeneral Practice 63476 (Minnesota)Secondary
2083X0100XPreventive Medicine - Occupational Medicine 63476 (Minnesota)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Healthpartners Medical Group17592939541430

News Archive

BioRx receives limited distribution rights from Baxter for AATD drug GLASSIA

BioRx, a specialty pharmacy company, has received limited distribution rights from Baxter International Inc. for a new drug, GLASSIA™ [Alpha 1-Proteinase Inhibitor (Human)], the first and only liquid, ready-to-use treatment for alpha-1 antitrypsin deficiency (AATD) in the United States. AATD is a genetic disorder that causes low levels of alpha 1-antitrypsin, resulting in emphysema. AATD is also referred to as "genetic" or "congenital" emphysema.

One in every 17 college students smokes marijuana on daily or near-daily basis

Daily marijuana use among the nation's college students is on the rise, surpassing daily cigarette smoking for the first time in 2014.

New mouse models resembles human ALS; may provide important tool for screening new drugs

A new mouse model of amyotrophic lateral sclerosis (ALS) closely resembles humans with the paralyzing disorder, researchers at Washington University School of Medicine in St. Louis report.

Cancer Research UK to unveil its eighth garden at Chelsea Flower Show 2010

Cancer Research UK will unveil its eighth garden at Chelsea Flower Show 2010 (25 - 29 May 2010), designed for the second year running by four-time gold medal winner, Robert Myers.

Read more Medical News

› Verified 5 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Manoj Doss allows following entities to bill medicare on his behalf.
Entity NamePark Nicollet Clinic
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1780621904
PECOS PAC ID: 7911819438
Enrollment ID: O20031104000046

News Archive

BioRx receives limited distribution rights from Baxter for AATD drug GLASSIA

BioRx, a specialty pharmacy company, has received limited distribution rights from Baxter International Inc. for a new drug, GLASSIA™ [Alpha 1-Proteinase Inhibitor (Human)], the first and only liquid, ready-to-use treatment for alpha-1 antitrypsin deficiency (AATD) in the United States. AATD is a genetic disorder that causes low levels of alpha 1-antitrypsin, resulting in emphysema. AATD is also referred to as "genetic" or "congenital" emphysema.

One in every 17 college students smokes marijuana on daily or near-daily basis

Daily marijuana use among the nation's college students is on the rise, surpassing daily cigarette smoking for the first time in 2014.

New mouse models resembles human ALS; may provide important tool for screening new drugs

A new mouse model of amyotrophic lateral sclerosis (ALS) closely resembles humans with the paralyzing disorder, researchers at Washington University School of Medicine in St. Louis report.

Cancer Research UK to unveil its eighth garden at Chelsea Flower Show 2010

Cancer Research UK will unveil its eighth garden at Chelsea Flower Show 2010 (25 - 29 May 2010), designed for the second year running by four-time gold medal winner, Robert Myers.

Read more Medical News

› Verified 5 days ago

Entity NameGroup Health Plan Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1710924683
PECOS PAC ID: 1759293954
Enrollment ID: O20031105000417

News Archive

BioRx receives limited distribution rights from Baxter for AATD drug GLASSIA

BioRx, a specialty pharmacy company, has received limited distribution rights from Baxter International Inc. for a new drug, GLASSIA™ [Alpha 1-Proteinase Inhibitor (Human)], the first and only liquid, ready-to-use treatment for alpha-1 antitrypsin deficiency (AATD) in the United States. AATD is a genetic disorder that causes low levels of alpha 1-antitrypsin, resulting in emphysema. AATD is also referred to as "genetic" or "congenital" emphysema.

One in every 17 college students smokes marijuana on daily or near-daily basis

Daily marijuana use among the nation's college students is on the rise, surpassing daily cigarette smoking for the first time in 2014.

New mouse models resembles human ALS; may provide important tool for screening new drugs

A new mouse model of amyotrophic lateral sclerosis (ALS) closely resembles humans with the paralyzing disorder, researchers at Washington University School of Medicine in St. Louis report.

Cancer Research UK to unveil its eighth garden at Chelsea Flower Show 2010

Cancer Research UK will unveil its eighth garden at Chelsea Flower Show 2010 (25 - 29 May 2010), designed for the second year running by four-time gold medal winner, Robert Myers.

Read more Medical News

› Verified 5 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Manoj Doss is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Manoj Doss, DO
8170 33rd Ave S,
Bloomington, MN 55425-4516

Ph: (651) 293-8100
Dr Manoj Doss, DO
9300 Hennepin Town Rd,
Eden Prairie, MN 55347-3072

Ph: (651) 280-8774

News Archive

BioRx receives limited distribution rights from Baxter for AATD drug GLASSIA

BioRx, a specialty pharmacy company, has received limited distribution rights from Baxter International Inc. for a new drug, GLASSIA™ [Alpha 1-Proteinase Inhibitor (Human)], the first and only liquid, ready-to-use treatment for alpha-1 antitrypsin deficiency (AATD) in the United States. AATD is a genetic disorder that causes low levels of alpha 1-antitrypsin, resulting in emphysema. AATD is also referred to as "genetic" or "congenital" emphysema.

One in every 17 college students smokes marijuana on daily or near-daily basis

Daily marijuana use among the nation's college students is on the rise, surpassing daily cigarette smoking for the first time in 2014.

New mouse models resembles human ALS; may provide important tool for screening new drugs

A new mouse model of amyotrophic lateral sclerosis (ALS) closely resembles humans with the paralyzing disorder, researchers at Washington University School of Medicine in St. Louis report.

Cancer Research UK to unveil its eighth garden at Chelsea Flower Show 2010

Cancer Research UK will unveil its eighth garden at Chelsea Flower Show 2010 (25 - 29 May 2010), designed for the second year running by four-time gold medal winner, Robert Myers.

Read more News

› Verified 5 days ago


Preventive Medicine Doctors in Eden Prairie, MN

Dr. Nicholas Nathan Sweet, D.O.
Preventive Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 11995 Singletree Ln Ste 500, Eden Prairie, MN 55344
Phone: 952-595-1301    Fax: 612-294-4903

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.